Healthcare IT Today July 30, 2024
Guest Author

The following is a guest article by Ravinder Singh, Senior Vice President, Consulting at CitiusTech

In recent years, Generative Artificial Intelligence (GenAI) has passed medical exams, diagnosed complex cases, and even come up with ways to combat a pandemic. In fact, LLMs such as GPT-4, Google’s BARD, Med-PaLM, ClinicalBERT, and BioGPT now perform complex tasks that can completely transform clinical decision-making and administrative efficiency. Unsurprisingly, GenAI in healthcare is expected to reach USD 22.1 Bn by 2032, driven by the demonstrated value in improving diagnostics, replicating patient responses, simulating disease progression, and synthesizing datasets for testing and training.

Revenue Cycle Management (RCM): The Strongest Use Case of GenAI in Healthcare

The financial backbone of healthcare, RCM, entails everything from payments...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), RCM (Revenue Cycle Mgmt), Technology
Related Articles:
Managed Care History Part III: The Rise of Machine-Driven Managed Care
Building Solutions To Turn Pain Points Into Opportunities In The Era Of AI
AI In R&D: Augmenting Scientific Discovery
Meta’s new BLT architecture replaces tokens to make LLMs more efficient and versatile
Johns Hopkins Medicine inks AI deal with Abridge

Share This Article